Publications by authors named "Tetsu Shinkai"

Claim this Profile
E
Effect of Trastuzumab Deruxtecan on QT/QTc Interval and Pharmacokinetics in HER2-Positive or HER2-Low Metastatic/Unresectable Breast Cancer.
Akihiko Shimomura, Toshimi Takano, Shunji Takahashi, Yasuaki Sagara, Junichiro Watanabe, Tetsu Shinkai

Clin Pharmacol Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of geriatric assessment in elderly patients with non-small cell lung cancer: an integrated analysis of two randomized phase III trials (JCOG1115-A).
Hiroshi Katayama, Junki Mizusawa, Haruhiko Fukuda, Shinichiro Nakamura, Kenich Nakamura, Tetsu Shinkai

Jpn J Clin Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913.
Yoshiro Nakahara, Tsuneo Shimokawa, Yuki Misumi, Naoyuki Nogami, Tetsu Shinkai

Invest New Drugs· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323.
Toshiyuki Kozuki, Naoyuki Nogami, Osamu Hataji, Yoshio Tsunezuka, Nobuhiko Seki, Tetsu Shinkai

Transl Lung Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Portal Vein Thrombosis in a Patient with Hereditary Antithrombin Deficiency.
Tamao Setaka, Katsuharu Hirano, Keiichi Moriya, Tougen Kaneko, Seie Morita, Tetsu Shinkai

Intern Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015.
Toshiyuki Kozuki, Naoyuki Nogami, Hiromoto Kitajima, Shunichiro Iwasawa, Emiko Sakaida, Tetsu Shinkai

BMC Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†.
Hiroko Tsukada, Akira Yokoyama, Koichi Goto, Tetsu Shinkai, Masao Harada

Jpn J Clin Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience.
Yuka Kato, Katsuyuki Hotta, Nagio Takigawa, Naoyuki Nogami, Toshiyuki Kozuki, Tetsu Shinkai

Cancer Chemother Pharmacol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Awareness about medical expenses and certifications of eligibility for limited health insurance payments for chemotherapy among clinicians at the Ehime Cancer Care Network Priority Hospitals (Ehime Cancer Kyoten Hospitals)].
Yoshihiro Yakushijin, Junko Morita, Takuya Yano, Tetsuaki Matsuhisa, Hitoshi Kawazoe, Tetsu Shinkai

Gan To Kagaku Ryoho· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study.
Kaoru Kubota, Toyoaki Hida, Satoshi Ishikura, Junki Mizusawa, Makoto Nishio, Tetsu Shinkai

Lancet Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of gastric cancer care in designated cancer care hospitals in Japan.
Takahiro Higashi, Fumiaki Nakamura, Yasuhiro Shimada, Tetsu Shinkai, Toru Muranaka

Int J Qual Health Care· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment.
Yasushi Hamamoto, Masaaki Kataoka, Motohiro Yamashita, Naoyuki Nogami, Yoshifumi Sugawara, Tetsu Shinkai

Jpn J Radiol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer.
Seiji Niho, Hideo Kunitoh, Hiroshi Nokihara, Takeshi Horai, Yukito Ichinose, Tetsu Shinkai

Lung Cancer· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting the local control of stereotactic body radiotherapy for lung tumors including primary lung cancer and metastatic lung tumors.
Yasushi Hamamoto, Masaaki Kataoka, Motohiro Yamashita, Naoyuki Nogami, Yoshifumi Sugawara, Tetsu Shinkai

Jpn J Radiol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemoradiotherapy.
Yasushi Hamamoto, Masaaki Kataoka, Naoyuki Nogami, Toshiyuki Kozuki, Yuka Kato, Tetsu Shinkai

Jpn J Radiol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401.
Naoyuki Nogami, Katsuyuki Hotta, Shoichi Kuyama, Katsuyuki Kiura, Nagio Takigawa, Tetsu Shinkai

Lung Cancer· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01).
Masaaki Kawahara, Harue Tada, Akihiro Tokoro, Satoshi Teramukai, Hideki Origasa, Tetsu Shinkai

BMC Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits and adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: analysis of the Okayama Lung Cancer Study Group trial 0007.
Nagio Takigawa, Katsuyuki Kiura, Yoshihiko Segawa, Katsuyuki Hotta, Akihiko Tamaoki, Tetsu Shinkai

J Thorac Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancer.
Nagio Takigawa, Katsuyuki Kiura, Katsuyuki Hotta, Shinobu Hosokawa, Naoyuki Nogami, Tetsu Shinkai

Lung Cancer· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implication of the antidiuretic hormone (ADH) receptor antagonist mozavaptan hydrochloride in patients with ectopic ADH syndrome.

Jpn J Clin Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II study.
Yuichi Takiguchi, Takashi Seto, Yukito Ichinose, Naoyuki Nogami, Tetsu Shinkai

J Thorac Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502.
Takashi Seto, Takeharu Yamanaka, Izumi Wasada, Nobuhiko Seki, Hiroaki Okamoto, Tetsu Shinkai

Lung Cancer· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Current status of adjuvant chemotherapy for resected lung cancer at our institute--focus on clinical trial enrollment].
Shigeki Sawada, Motohiro Yamashita, Eisaku Komori, Hiroshi Suehiro, Atsuko Ogino, Tetsu Shinkai

Gan To Kagaku Ryoho· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer.
Yasushi Hamamoto, Masaaki Kataoka, Motohiro Yamashita, Tetsu Shinkai, Yoshiro Kubo

Jpn J Clin Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group.
Kenichi Inoue, Kazuhiko Nakagami, Mitsuhiro Mizutani, Yasuo Hozumi, Yasuhiro Fujiwara, Tetsu Shinkai

Breast Cancer Res Treat· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis